Related Experiment Video
Updated: Jun 22, 2025

09:37
Chronic Stress Shifts Effort-Related Choice Behavior in a Y-Maze Barrier Task in Mice
Published on: August 13, 2020
11.1K
Major depression symptom severity associations with willingness to exert effort and patch foraging strategy
Laura A Bustamante1,2, Deanna M Barch1, Johanne Solis3
1Washington University in St. Louis.
Medrxiv : the Preprint Server for Health Sciences
|July 1, 2024
Summary
Major depressive disorder (MDD) impacts goal-directed behavior, but effort-based decision-making measures did not differ between individuals with MDD and controls. However, specific symptoms like anxiety and anhedonia were linked to distinct effort cost patterns.
Area of Science:
- Cognitive Neuroscience
- Psychiatry
- Behavioral Economics
Background:
- Major depressive disorder (MDD) is associated with impaired motivation and cognitive function, affecting goal-directed behaviors.
- Individuals typically maximize expected value by balancing potential rewards against costs, including effort and opportunity costs.
- Altered cost-benefit analysis in MDD may explain variations in cognitive symptoms and heterogeneity.
Purpose of the Study:
- To quantify cognitive and physical effort costs and patch leaving thresholds in individuals with MDD.
- To investigate the relationship between these decision-making measures and clinical features of MDD.
- To explore potential mechanisms underlying MDD heterogeneity through effort-based decision-making.
Main Methods:
- Utilized the Effort Foraging Task to assess effort costs and decision-making.
- Included participants with MDD (N=52) and comparison groups (N=27).
- Examined relationships between decision-making measures and clinical symptom severity, controlling for ability.
Main Results:
- No significant differences in decision-making measures were found between MDD and control groups.
- Effort-based decision-making measures correlated with symptom severity, independent of cognitive ability.
- Anxiety symptoms linked to lower cognitive effort cost; anhedonia and apathy linked to higher physical effort costs; depression severity linked to decreased patch leaving thresholds.
Conclusions:
- Effort-based decision-making markers may help understand MDD heterogeneity.
- Increased cognitive effort willingness may relate to anxiety; reduced vigor in MDD may relate to leaving thresholds.
- Future research should explore depression subtypes, particularly those with and without anxiety, in relation to cognitive effort.
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
91
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
91
Depressive Disorders: Etiology
63
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
63
Depression: Overview
237
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
237
Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215

